ANANDA PHARMA LIMITED
11159584Activities of venture and development capital companies
ANANDA PHARMA LIMITED
Activities of venture and development capital companies
Previous Company Names
Contact & Details
Contact
Registered Address
C/O Arch Law Limited Huckletree Bishopsgate 8 Bishopsgate London EC2N 4BQ United Kingdom
Full company profile for ANANDA PHARMA LIMITED (11159584), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 19 Jan 2018. Activities of venture and development capital companies. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2018–2024)
Cash in Bank
£1.66M
Net Assets
£2.13M
Total Liabilities
£2.50M
Turnover
£1.00k
Employees
9
Debt Ratio
54%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Jan Year End | 2024 31 Jan Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 11 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Charles Waite Morgan
Ceased 11 Jun 2019
Melissa Josephine Sturgess
Ceased 11 Jun 2019
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 18 Jun 2026 | Officers | Termination of John Michael Treacy as director on 18 Jun 2026 | |
| 16 Feb 2026 | Confirmation Statement | Confirmation statement made on 27 Jan 2026 with no updates | |
| 10 Feb 2026 | Capital | Allotment of shares (GBP 8,898,293.16) on 9 Dec 2025 | |
| 8 Jan 2026 | Change Of Name | Reregistration Public To Private Company | |
| 8 Jan 2026 | Incorporation | Re Registration Memorandum Articles |
Termination of John Michael Treacy as director on 18 Jun 2026
Confirmation statement made on 27 Jan 2026 with no updates
Allotment of shares (GBP 8,898,293.16) on 9 Dec 2025
Reregistration Public To Private Company
Re Registration Memorandum Articles
Recent Activity
Latest Activity
Termination of John Michael Treacy as director on 18 Jun 2026
2 weeks ago on 18 Jun 2026
Confirmation statement made on 27 Jan 2026 with no updates
4 months ago on 16 Feb 2026
Allotment of shares (GBP 8,898,293.16) on 9 Dec 2025
4 months ago on 10 Feb 2026
Reregistration Public To Private Company
5 months ago on 8 Jan 2026
Re Registration Memorandum Articles
5 months ago on 8 Jan 2026